Drugs / Prepandrix™
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | Prepandrix | — | 2020-12-17 | europa.eu ↗ |
| Approved | EU (EMA) | Prepandrix | — | 2008-05-14 | europa.eu ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01730378 | Dec 2012 → Dec 2013 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prepandrix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01730378 ↗ |